Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 3, Issue 6, 2006, Pages 499-501

  Lomas, David A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Cirrhosis; Emphysema; Polymerization; Polymers; Serpin

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERINE PROTEINASE INHIBITOR;

ANGIONEUROTIC EDEMA; BETA SHEET; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONFORMATION; DEMENTIA; DISEASE ASSOCIATION; EMPHYSEMA; GENETIC LINKAGE; HUMAN; INFLAMMATION; LIVER CELL; POINT MUTATION; PROTEIN DEFICIENCY; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; SERPINOPATHY; THROMBOSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BLOOD; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; SMOKING;

ALPHA 1-ANTITRYPSIN DEFICIENCY; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SERPINS; SMOKING;

EID: 33747842761     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200603-069MS     Document Type: Conference Paper

References (29)

1. 1-antitrypsin accumulation in the liver. Nature 1992;357:605-607.
2. 1-antitrypsin. J Biol Chem 1999;274:9548-9555.
3. 1-antitrypsin polymers are formed by reactive loop-β-sheet A linkage. J Biol Chem 2000;275:33663-33668.
4. 1-antitrypsin related cirrhosis. J Biol Chem 2002;277:6771-6774.
5. 1-antichymotrypsin indicates two stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 2000;97:67-72.
6. 1-antitrypsin. Hepatology 2004;40:1203-1210.
7. 1-Antitrypsin polymerisation: a fluorescence correlation spectroscopic study. Biochemistry 2005;44:2642-2649.
8. An JK, Blomenkamp K, Lindblad D, Teckman JH. Quantitative isolation of alpha-l-antitrypsin mutant Z protein polymers from human and mouse livers and the effect of heat. Hepatology 2005;41:160-167.
9. Lomas DA, Mahadeva R. Alpha-1-antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110:1585-1590.
10. 1-antitrypsin deficiency: a model for conformational diseases. N Engl J Med 2002;346:45-53.
11. Corral J, Aznar J, Gonzalez-Conejero R, Villa P, Minano A, Vaya A, Carrell RW, Huntington JA, Vicente V. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. Circulation 2004;110:1303-1307.
12. Green C, Brown G, Dafforn TR, Reichhart JM, Morley T, Lomas DA, Gubb D. Drosophila necrotic mutations mirror disease-associated variants of human serpins. Development 2003;130:1473-1478.
13. Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, Sonderegger P, Kinter J, Becker LM, Lacbawan F, et al. Familial dementia caused by polymerisation of mutant neuroserpin. Nature 1999;401:376-379.
14. 53→Phe): further evidence for intracellular loop-sheet polymerisation. J Biol Chem 1993;268:15333-15335.
15. Davis RL, Shrimpton AE, Carrell RW, Lomas DA, Gerhard L, Baumann B, Lawrence DA, Yepes M, Kim TS, Piccardo P, et al. Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet 2002;359:2242-2247.
16. Lomas DA, Belorgey D, Mallya M, Miranda E, Kinghorn KJ, Sharp LK, Phillips RL, Page R, Robertson AS, Crowther DC. Molecular mousetraps and the serpinopathies. Biochem Soc Trans 2005;33:321-330.
17. Lomas DA, Belorgey D, Mallya M, Onda M, Kinghorn KJ, Sharp LK, Phillips RL, Page R, Crowther DC, Miranda E. Polymerisation underlies alpha-1-antitrypsin deficiency, dementia and other serpinopathies. Front Biosci 2004;9:2873-2891.
18. 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 1987;80:1366-1374.
19. 1- antitrypsin. Biochemistry 1993;32:500-508.
20. 1- antitrypsin related emphysema. Am J Respir Cell Mol Biol 1998;18:670-674.
21. 1- antitrypsin co-localise with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;166:377-386.
22. 1-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 2002;26:723-730.
23. 1-Antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 2004;125:1952-1957.
24. 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) 1987;72:373-381.
25. 1-antitrypsin deficiency. Chest 2000;117:250S-251S.
26. 1-antitrypsin administration and liver transplantation. Transplantation 1997;63:480-482.
27. 1-antitrypsin deficiency [abstract]. Am J Respir Crit Care Med 2001;163:A343.
28. 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994;236:543-548.
29. 1- antitrypsin deficiency. Am J Respir Crit Care Med 1997;156:68-74.